CLOs on the Move


 
Cybin is a leading biotechnology company focused on progressing psychedelic therapeutics by utilizing proprietary drug-discovery platforms, innovative drug-delivery systems, novel formulation approaches and treatment regimens for psychiatric disorders.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.cybin.com
  • 5600-100 King Street West
    Toronto, ON CAN M5X 1C9
  • Phone: 416.567.4675

Executives

Name Title Contact Details
Robert Mino
General Counsel and Intellectual Property Counsel Profile
Robert Mino
General Counsel and IP Counsel Profile
Lori Challenger
Chief Compliance, Ethics and Administrative Officer Profile

Similar Companies

Taiga Biotechnologies Inc

Taiga Biotechnologies is a privately-held developer of novel therapies for complex diseases including cancers, infectious agents such as HIV and influenza, and hematologic conditions.

DermTech International

DermTech International is a La Jolla, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

DMC

DMC is leading the low cost sustainable transformation of multiple product markets.

Elusys Therapeutics

Elusys Therapeutics is a Pine Brook, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Revvity

At Revvity, “impossible” is inspiration, and ""can`t be done"" is a call to action. Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what`s possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. With more than $3 billion in revenue and over 11,000 employees, Revvity serves customers across pharmaceutical and biotech, diagnostic labs, academia and governments. It is part of the S&P 500 index and has customers in more than 190 countries.